Galectin Therapeutics
GALT
#8251
Rank
ยฃ0.12 B
Marketcap
ยฃ1.95
Share price
0.59%
Change (1 day)
19.06%
Change (1 year)

Earnings for Galectin Therapeutics (GALT)

Earnings in 2024 (TTM): -ยฃ35.28 Million

According to Galectin Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ31.58 Million a decrease over its 2022 earnings that were of -ยฃ29.82 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Galectin Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ35.28 Million11.71%
2023 -ยฃ31.58 Million5.91%
2022 -ยฃ29.82 Million27.02%
2021 -ยฃ23.48 Million30.1%
2020 -ยฃ18.05 Million76.51%
2019 -ยฃ10.23 Million-4.36%
2018 -ยฃ10.69 Million-14.38%
2017 -ยฃ12.49 Million-24.26%
2016 -ยฃ16.49 Million7.04%
2015 -ยฃ15.4 Million26.85%
2014 -ยฃ12.15 Million30.61%
2013 -ยฃ9.3 Million27.82%
2012 -ยฃ7.28 Million-9.15%
2011 -ยฃ8.01 Million113.17%
2010 -ยฃ3.76 Million-19.86%
2009 -ยฃ4.69 Million14.4%
2008 -ยฃ4.1 Million-17.49%
2007 -ยฃ4.97 Million-8.41%
2006 -ยฃ5.42 Million5.91%
2005 -ยฃ5.12 Million-8.89%
2004 -ยฃ5.62 Million47.92%
2003 -ยฃ3.8 Million50.22%
2002 -ยฃ2.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ0.59 Billion 1,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.67 M-131.36%๐Ÿ‡บ๐Ÿ‡ธ USA